| Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability PJM Brouwer, TG Caniels, K van der Straten, JL Snitselaar, Y Aldon, ... Science 369 (6504), 643-650, 2020 | 1223 | 2020 |
| Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity MD Larsen, EL de Graaf, ME Sonneveld, HR Plomp, J Nouta, W Hoepel, ... Science 371 (6532), eabc8378, 2021 | 337 | 2021 |
| Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity H Liu, NC Wu, M Yuan, S Bangaru, JL Torres, TG Caniels, ... Immunity 53 (6), 1272-1280. e5, 2020 | 216 | 2020 |
| High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages W Hoepel, HJ Chen, CE Geyer, S Allahverdiyeva, XD Manz, SW de Taeye, ... Science translational medicine 13 (596), eabf8654, 2021 | 187 | 2021 |
| Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle PJM Brouwer, A Antanasijevic, Z Berndsen, A Yasmeen, B Fiala, TPL Bijl, ... Nature Communications 10 (1), 4272, 2019 | 169 | 2019 |
| Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ... Cell 184, 1-13, 2021 | 165 | 2021 |
| An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain NC Wu, M Yuan, H Liu, CCD Lee, X Zhu, S Bangaru, JL Torres, ... Cell reports 33 (3), 2020 | 160 | 2020 |
| Tailored Design of Protein Nanoparticle Scaffolds for Multivalent Presentation of Viral Glycoprotein Antigens G Ueda, A Antanasijevic, JA Fallas, W Sheffler, J Copps, D Ellis, ... Elife, 2020 | 139 | 2020 |
| Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence K Sliepen, BW Han, I Bontjer, P Mooij, F Garces, AJ Behrens, ... Nature communications 10 (1), 2355, 2019 | 136 | 2019 |
| Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva TJ Ketas, D Chaturbhuj, VMC Portillo, E Francomano, E Golden, ... Pathogens and Immunity 6 (1), 116, 2021 | 130 | 2021 |
| Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare … S Pickering, G Betancor, RP Galao, B Merrick, AW Signell, HD Wilson, ... Plos Pathogens, 2020 | 125 | 2020 |
| Cross-reactive antibodies after SARS-CoV-2 infection and vaccination M Grobben, K van der Straten, PJM Brouwer, M Brinkkemper, ... Elife 10, e70330, 2021 | 89 | 2021 |
| Site-specific steric control of SARS-CoV-2 spike glycosylation JD Allen, H Chawla, F Samsudin, L Zuzic, AT Shivgan, Y Watanabe, W He, ... Biochemistry 60 (27), 2153-2169, 2021 | 68 | 2021 |
| Human milk from previously COVID-19-infected mothers: the effect of pasteurization on specific antibodies and neutralization capacity BJ van Keulen, M Romijn, A Bondt, KA Dingess, E Kontopodi, ... Nutrients 13 (5), 1645, 2021 | 65 | 2021 |
| Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens A Antanasijevic, G Ueda, J Copps, PJM Brouwer, D Huang, JD Allen, ... Plos Pathogens, 2020 | 61 | 2020 |
| Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses W Hoepel, HJ Chen, S Allahverdiyeva, X Manz, J Aman, ... BioRxiv, 2020.07. 13.190140, 2020 | 59 | 2020 |
| Infection and transmission of SARS‐CoV‐2 depend on heparan sulfate proteoglycans M Bermejo‐Jambrina, J Eder, TM Kaptein, JL van Hamme, LC Helgers, ... The EMBO Journal 40 (20), e106765, 2021 | 57 | 2021 |
| COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ... Nature communications 12 (1), 6097, 2021 | 47 | 2021 |
| A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike M Claireaux, TG Caniels, M de Gast, J Han, D Guerra, G Kerster, ... Nature communications 13 (1), 4539, 2022 | 42 | 2022 |
| Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles PJM Brouwer, A Antanasijevic, M de Gast, JD Allen, TPL Bijl, A Yasmeen, ... npj Vaccines 6 (24), 2021 | 39 | 2021 |
